US Fertility launches Research Division to drive innovation in reproductive health

US Fertility’s newly formed Research Division will conduct and publish research studies to advance the field of reproductive medicine to provide better care and improve pregnancy outcomes.

Its Research Division will be led by Kate Devine, M.D., executive medical director and chief research officer at US Fertility, in close collaboration with Luis Hoyos, M.D., regional research director and practicing reproductive endocrinologist, Meike Uhler, M.D., regional research director and practicing reproductive endocrinologist, Samad Jahandideh, Ph.D., head of clinical biostatistics at US Fertility and others.

US Fertility is the largest network of physician-owned and physician-led fertility practices in the country.

With more than 130,000 babies born to its credit, US Fertility completes more than 30,000 fresh IVF cycles annually, nearly 70,000 cycles total, include frozen embryo transfers, and performs 1,000+ elective and donor egg freezing cycles annually.

“Given our culture, commitment to excellence, incredible volume of data, and unparalleled talent, there’s no limit to what we can accomplish as a network,” says Dr Devine, a practicing, board-certified reproductive endocrinologist and fertility physician at Shady Grove Fertility – a founding partner practice of US Fertility..

“Our Research Division celebrates the amazing contributions our research and education teams are making in collaboration across the US Fertility network, a network of innovation.”

US Fertility’s Research Division announcement arrives as the organisation gears up for a significant presence at the upcoming annual American Society for Reproductive Medicine (ASRM) Scientific Congress and Expo, taking place this week in Anaheim, California.

Researchers from across the US Fertility network are showcasing abstracts, delivering oral presentations, and receiving research prizes during the event.

“Our team is hard at work educating the next generation of providers and embryologists to care for future patients struggling with infertility. 2022 represents the showing of some of our best research to date,” Devine adds.

“I feel so privileged to work at an organisation that values research and helps facilitate this amazing work.”